Diagnosis and Management of Immediate Hypersensitivity Reactions to Cephalosporins

被引:39
作者
Dickson, Scott D. [1 ]
Salazar, Kimberly C. [2 ]
机构
[1] Wilford Hall Ambulatory Surg Ctr, Dept Allergy & Immunol, Joint Base San Antonio Lackland, San Antonio, TX 78236 USA
[2] San Antonio Mil Med Ctr, Dept Med, Joint Base San Antonio Ft Sam Houston, San Antonio, TX USA
关键词
Cephalosporins; Immediate hypersensitivity; IgE mediated; Diagnosis; Management; IGE-MEDIATED HYPERSENSITIVITY; BASOPHIL ACTIVATION TEST; BETA-LACTAM ANTIBIOTICS; CROSS-REACTIVITY; ALLERGIC REACTIONS; ANTIGENIC DETERMINANTS; PENICILLIN; CEFAZOLIN; ANTIBODIES; RECOGNITION;
D O I
10.1007/s12016-013-8367-x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Cephalosporins are one of the most commonly prescribed classes of antibiotics. Immediate IgE-mediated hypersensitivity reactions have been reported with use of a specific cephalosporin, as a cross-reaction between different cephalosporins or as a cross-reaction to other beta-lactam antibiotics, namely, penicillin. Historically, frequent reports of anaphylaxis following administration of first- and second-generation cephalosporins to patients with a history of penicillin allergy led to the belief of a high degree of allergic cross-reactivity. More recent evidence reveals a significantly lower risk of cross-reactivity between penicillins and the newer-generation cephalosporins. The current thought is that a shared side chain, rather than the beta-lactam ring structure, is the determining factor in immunologic cross-reactivity. Understanding the chemical structure of these agents has allowed us to identify the allergenic determinants for penicillin; however, the exact allergenic determinants of cephalosporins are less well understood. For this reason, standardized diagnostic skin testing is not available for cephalosporins as it is for penicillin. Nevertheless, skin testing to the cephalosporin in question, using a nonirritating concentration, provides additional information, which can further guide the work-up of a patient suspected of having an allergy to that drug. Together, the history and the skin test results can assist the allergist in the decision to recommend continued drug avoidance or to perform a graded challenge versus an induction of tolerance procedure.
引用
收藏
页码:131 / 142
页数:12
相关论文
共 84 条
[1]   Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations [J].
Aberer, W ;
Bircher, A ;
Romano, A ;
Blanca, M ;
Campi, P ;
Fernandez, J ;
Brockow, K ;
Pichler, WJ ;
Demoly, P .
ALLERGY, 2003, 58 (09) :854-863
[2]  
ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
[3]   IgE antibodies to betalactams:: relationship between the triggering hapten and the specificity of the immune response [J].
Antunez, C. ;
Fernandez, T. ;
Blanca-Lopez, N. ;
Torres, M. J. ;
Mayorga, C. ;
Canto, G. ;
Fernandez, J. ;
Moya, M. C. ;
Blanca, M. .
ALLERGY, 2006, 61 (08) :940-946
[4]   Immediate allergic reactions to cephalosporins:: Evaluation of cross-reactivity with a panel of penicillins and cephalosporins [J].
Antunez, C ;
Blanca-Lopez, N ;
Torres, MJ ;
Mayorga, C ;
Perez-Inestrosa, E ;
Montañez, MI ;
Fernandez, T ;
Blanca, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) :404-410
[5]   Type-I hypersensitivity to ceftriaxone and cross-reactivity with cefalexin and ampicillin [J].
Atanaskovic-Markovic, M ;
Gavrovic-Jankulovic, M ;
Velickovic, TC ;
Vuckovic, O ;
Todoric, D .
ALLERGY, 2003, 58 (06) :537-538
[6]   ALLERGIC REACTIONS TO BETA-LACTAMS - STUDIES IN A GROUP OF PATIENTS ALLERGIC TO PENICILLIN AND EVALUATION OF CROSS-REACTIVITY WITH CEPHALOSPORIN [J].
AUDICANA, M ;
BERNAOLA, G ;
URRUTIA, I ;
ECHECHIPIA, S ;
GASTAMINZA, G ;
MUNOZ, D ;
FERNANDEZ, E ;
DECORRES, LF .
ALLERGY, 1994, 49 (02) :108-113
[7]  
Baldo BA, 1999, CLIN EXP ALLERGY, V29, P744
[8]   Immunoglobulin E binding determinants on β-lactam drugs [J].
Baldo, Brian A. ;
Pham, Nghia H. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 2 (04) :297-300
[9]  
Barbaud A, 1998, BRIT J DERMATOL, V139, P49
[10]  
BATCHELOR FR, 1966, IMMUNOLOGY, V10, P21